Diagnosing and treating complex health conditions has always been a challenge for healthcare professionals. In response, we are in the era of personalized or precision medicine, an approach that seeks to tailor prevention and treatment strategies to a person’s unique characteristics, such as their genetics, comorbidities and environment, tech.eu writes.
Technology plays a crucial role in the development of personalized medicine, and biomedical and healthcare startups are at the forefront of innovation and will change the future of medicine.
The one-size-fits-all approach is often ineffective in healthcare. Personalised medicine aims to provide a more tailored approach. This is also why a number of startups are developing health technologies that take into account patients’ unique genetic, biological and environmental factors.
Avatar Medical (France)
Avatar Medical creates real-time ED patient avatars to help clinicians and surgeons visualise medical images.The company’s VR solution helps surgeons better prepare their procedures by interacting with an ultra-fluid, photo-realistic VR representation of their patient’s medical images.
The solution is beneficial for understanding complex biological structures to help avoid mastectomies, shorten the operating time for reconstructive surgeries and inform hardware selection. Use cases include vascular, orthopedic, and head and neck surgery.
Biomesight is an AI-driven wellness analytics platform primarily focusing on the gut microbiome.
Over the past two decades, researchers are exploring the gut microbiota for potential gut microbe–host interactions, including the impact on metabolism, immune, and neuroendocrine responses.
The Biomesight test provides a snapshot of the gut microbiome utilizing 16S rRNA sequencing technology. This is then interpreted against recommended ranges for a subset of key bacteria (Probiotics, Commensals and Pathogens) and combined with other metrics to offer personalized recommendations for diet, prebiotic supplements and lifestyle adjustments.
Strike Pharma (Sweden)
Founded in 2020, Strike Pharma has developed proprietary Adaptable Drug Affinity Conjugate (ADAC) technology to take precision medicine to a new level. This makes it possible to create truly individualized immunotherapeutic treatments based on the genetic profile of a patient’s tumor.
Personalized genetics can increase therapeutic efficacy, and reduce dosage levels, thereby minimizing the risk of side effects.